2 Lesser-Known Energy Stocks to Buy as Oil Approaches $70

: OVV | Ovintiv Inc. News, Ratings, and Charts

OVV – On one hand, increasing mobility and rising demand from a reopening industrial sector is driving the demand for oil. On the other hand, the world’s largest oil producing countries are continuing with supply cuts. We think the resulting increase in oil prices should help lesser-known oil energy companies Ovintiv (OVV) and Crescent Point (CPG) perform well in the coming months. So, it could be wise to bet on these stocks now. Read on for a closer look at these names.

The rising demand for oil with increasing mobility and a reopening of the industrial sector, coupled with continued supply cuts by the major oil producing countries, is driving a  surge in oil prices. Goldman Sachs expects crude oil to rise to $80 per barrel by the end of the year. This bodes well for oil companies. According to a Research and Markets report, the global oil and gas pipeline market is expected to grow at a CAGR of more than 6% between 2021-2026.

Investors’ interest in the oil energy stocks is evident in SPDR S&P Oil & Gas Exploration & Production ETF’s (XOP) 17.9% gains over the past month compared to the SPDR S&P 500 Trust ETF’s (SPY) 0.2% returns.

Given this backdrop, we think it could be wise to scoop up the stocks of lesser-known oil energy companies Ovintiv Inc. (OVV) and Crescent Point Energy Corp. (CPG) because they are expected to continue benefiting from rising oil prices.

Ovintiv Inc. (OVV)

Formerly known as Encana Corporation, OVV was incorporated in 2020 and engages in the exploration, development, production, and marketing of natural gas, oil, and natural gas liquids. It operates through its USA Operations, Canadian Operations, and Market Optimization segments. The company’s principal assets include Permian in West Texas and Anadarko in West-Central Oklahoma.

OVV closed its Eagle Ford asset sale on May 19, 2021. The proceeds from this sale, combined with its Duvernay asset sale, will be used for debt reduction. Ovintiv CEO Doug Suttles said “Our priorities today are clear–reduce debt, maintain scale, drive efficiencies, and return cash to shareholders.”

OVV’s non-GAAP operating earnings increased 985.2% year-over-year to $293 million in the first quarter, ended March 31, 2021. Its adjusted net earnings before income tax grew 1425.9% year-over-year to $412 million. And its  non-GAAP cash flow came in at $890 million, which represents a 66.3% year-over-year increase.

Analysts expect OVV’s EPS to increase 3,400% year-over-year to $0.99 for the quarter ending September 30, 2021. It surpassed consensus EPS estimates in each of the trailing four quarters. The company’s revenue is expected to increase 37.8% year-over-year to $1.71 billion for the current quarter, ending June 30, 2021. The stock has gained 229.7% over the past year to close yesterday’s trading session at $29.61.

OVV’s strong fundamentals are reflected in its POWR Ratings. The stock has an overall B rating, which equates to Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.

It has an A grade for Momentum, and a B grade for Growth. We have also graded OVV for Value, Quality, Sentiment and Stability. Click here to access all OVV’s ratings. OVV is ranked #14 of 51 stocks in B-rated Foreign Oil & Gas industry.

Crescent Point Energy Corp. (CPG)

CPG explores, develops, and produces light and medium crude oil and natural gas reserves in Western Canada and the United States. Its crude oil and natural gas properties and related assets are in the provinces of Saskatchewan, Alberta, British Columbia, and Manitoba.

On April 1, 2021, CPG acquired Shell Canada Energy’s Kaybob Duvernay assets in Alberta for $900 million. The strategic acquisition comports with CPG’s core principles of balance sheet strength and sustainability. The transaction is expected to enhance the company’s free cash flow profile and inventory depth and will  include key infrastructure that is expected to lower future capital requirements.

CPG’s net debt decreased 13.5% year-over-year to $2.01 billion in the first quarter, ended March 31, 2021. Its adjusted net earnings from operations grew 95.3% year-over-year to $95.1 million. Its net income came in at $21.4 million versus  a $2.32 billion net loss in the prior-year period.

For  2022, analysts expect CPG’s EPS to increase 70.74% year-over-year to $0.68. For the current quarter, ending June 30, 2021, its revenue is expected to increase 212.1% year-over-year to $601.09 million. The stock has soared 190.2% over the past year to close yesterday’s trading session at $4.76.

CPG’s POWR Ratings reflect this promising outlook. The company has an overall B rating, which translates to Buy in our proprietary ratings system. The stock has an A grade for Momentum, and a B grade for Growth and Quality.

Within the Foreign Oil & Gas industry, CPG is ranked #16. To see all the POWR Ratings for CPG (Stability, Value and Sentiment), click here.

Want More Great Investing Ideas?

7 SEVERELY Undervalued Stocks

9 “Must Own” Growth Stocks for 2021

How to Trade The NEW Stock Market Bubble?

5 Ways to Beat the S&P 500


OVV shares were trading at $30.72 per share on Thursday afternoon, up $1.11 (+3.75%). Year-to-date, OVV has gained 113.93%, versus a 12.49% rise in the benchmark S&P 500 index during the same period.


About the Author: Nimesh Jaiswal


Nimesh Jaiswal's fervent interest in analyzing and interpreting financial data led him to a career as a financial analyst and journalist. The importance of financial statements in driving a stock’s price is the key approach that he follows while advising investors in his articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
OVVGet RatingGet RatingGet Rating
CPGGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

Investor Alert: Keep Calm and Carry On

The stock market (SPY) took a scary turn on Monday as news of Evergrande culminated in a worldwide sell off. Now with a little time and perspective investors see this was more smoke than actual fire creating a buy the dip event. Why did this happen? And where do stocks head next? Read on for those answers and more below...

:  |  News, Ratings, and Charts

2022 Stock Market Outlook

The stock market (SPY) has continued on a bullish path in 2021. Will that continue in 2022? And what could happen to awaken the bear market from hibernation? 40 year investment veteran Steve Reitmeister explores this and more in this early edition of his 2022 Stock Market Outlook. Read on for full details below...

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

:  |  News, Ratings, and Charts

3 Value Stocks to Buy While You Still Can

After outperforming from last fall into the spring, value stocks have been overtaken by growth stocks, but that is expected to change as the economic recovery continues. So, now is the time to start putting your money to work in undervalued companies that offer the potential for strong returns such as Gilead Sciences Inc. (GILD), HP Inc. (HPQ), and CNH Industrial N.V. (CNHI).

:  |  News, Ratings, and Charts

3 Cheap Healthcare Stocks to Buy Right Now

Healthcare stocks saw renewed interest due to the onset of the pandemic, but It’s not only COVID that is driving returns. The Baby Boomer generation is getting older, which is resulting in increased demand for healthcare products and services. That’s why investors should consider adding undervalued healthcare stocks such as Ironwood Pharmaceuticals, Inc. (IRWD), Nu Skin Enterprises, Inc. (NUS), and Bristol-Myers Squibb Co. (BMY) to their portfolio.

Read More Stories

More Ovintiv Inc. (OVV) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All OVV News